Mumbai,February 03, 2018: Pharma major Lupin announced the launch of its Clobetasol Propionate Lotion 0.05% having received an approval from the United States Food and Drug Administration (FDA) earlier.
Lupin’s Clobetasol Propionate Lotion 0.05 percent is the generic equivalent of Galderma Labs’ Clobex lotion.
It is indicated for the relief of the inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, in patients 18 years of age or older.
United News of India
